Semax 7000 Nasal Spray
Semax 7000 Nasal Spray contains the synthetic heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro in a 10 ml intranasal format.
Researchers developed Semax from adrenocorticotropic hormone (ACTH), although Semax does not produce ACTH’s hormonal activity. Intranasal delivery also avoids many of the challenges that peptide compounds face in the gastrointestinal tract, including enzymatic degradation, instability and poor permeability.
In cognitive and recovery-focused settings, research has primarily explored Semax for attention, memory and neuroprotective support. Its activity differs from anabolic, endocrine or conventional stimulant compounds.
How Semax Works
Semax influences neurological function through neurotrophic and monoaminergic pathways rather than classic hormonal signalling.
Research links intranasal Semax with changes in brain-derived neurotrophic factor (BDNF) expression and related TrkB signalling. In addition, studies suggest that Semax may influence monoamine systems and gene-expression pathways involved in immune and vascular responses within injured brain tissue.
Together, these findings support its classification as a regulatory neuropeptide rather than a steroid, anabolic agent or conventional stimulant.
Properties and Effects
- Supports attention and short-term memory
- May help maintain focus and mental clarity
- May influence BDNF-related neurotrophic pathways
- Offers potential neuroprotective support during neurological stress
- Functions through neuroregulatory rather than anabolic pathways
- Lacks steroid, testosterone and growth-hormone activity
Recommended Use
Research and clinical-style literature have explored Semax mainly in protocols focused on:
- Cognitive support
- Attention and focus
- Memory
- Mental performance
- Neurorecovery-oriented support
Furthermore, much of the available human literature uses intranasal administration. Researchers have focused on neurological and cognitive applications rather than muscle gain, hormonal enhancement or aggressive stimulation.
Overall, Semax occupies a very different category from anabolic peptides or hormone-based products.
Mechanism of Action
Several neurological pathways may contribute to the activity of Semax.
Firstly, studies suggest that Semax affects neurotrophic signalling, including pathways involving BDNF and TrkB.
Secondly, researchers have observed effects on monoaminergic systems involved in neurological function.
Furthermore, preclinical studies have identified changes in gene-expression pathways associated with immune and vascular responses following neurological injury.
These findings support a broader neuroregulatory mechanism rather than a conventional endocrine action.
Safety and Side Effects
Human studies provide limited safety data, and researchers have not yet established the long-term safety profile of Semax.
Reviewed human use has reported effects that include:
- Nasal cavity discolouration in approximately 10% of patients
- Increased blood glucose in approximately 7.4% of patients with diabetes
However, the underlying human literature remains limited.
Semax does not function as an anabolic or endocrine compound. Consequently, available descriptions do not associate it with testosterone suppression or aromatisation.
Special Notes
Semax belongs to the category of neuroactive regulatory and nootropic peptides.
It differs from:
- Steroids
- SARMs
- SERMs
- Testosterone products
- Growth hormone
Instead, research primarily focuses on its potential role in attention, memory, cognitive performance and nervous-system support.
Dosage Information
The 10 ml bottle contains a total of:
7000 mcg Semax
This concentration provides:
700 mcg per ml
Actual dose per spray depends on the calibrated output of the nasal pump. Therefore, the dose per spray should not be assumed unless the pump volume is confirmed.
Published human literature has used different Semax concentrations and administration schedules. However, these research protocols do not establish a universal dosing schedule for every commercial nasal spray.
Consult your healthcare provider for personalized guidance.
Timing of Doses
Available literature generally describes Semax use during the daytime.
For example, some research involving healthy individuals used twice-daily administration. By contrast, neurological recovery protocols have investigated more frequent daytime administration.
Researchers have also studied neurological changes within minutes of a single intranasal dose.
However, current evidence does not establish one standard timing schedule across all Semax formulations.
Practical Guidance
Semax functions more like a consistency-based neuroregulatory peptide than a conventional stimulant.
Because pump output determines the actual amount delivered with each spray, accurate pump calibration matters.
For appropriate product care:
- Minimise unnecessary heat exposure
- Avoid excessive agitation
- Maintain good nozzle hygiene
- Follow the storage instructions on the packaging
Although research has explored potential cognitive and neuroprotective applications, human evidence remains limited. Modern, large-scale clinical trials have not yet standardised its use.
Directions for Use
Use strictly according to the manufacturer’s instructions and product label.
Product Information
Product: Semax 7000 Nasal Spray
Format: Intranasal Spray
Bottle Size: 10 ml
Total Semax: 7000 mcg
Concentration: 700 mcg/ml
Peptide Sequence: Met-Glu-His-Phe-Pro-Gly-Pro
Important Information
Semax is a biologically active peptide.
Therefore, consult an appropriately qualified healthcare professional before use, particularly if you take medication, have diabetes, have a neurological condition, are pregnant or breastfeeding, or live with another existing medical condition.
Keep out of reach of children.
Storage
Follow the storage instructions printed on the product packaging.
In addition, protect the product from unnecessary heat and light.
Disclaimer
This information is intended for general educational purposes and does not replace medical advice, diagnosis or treatment.
Human research on Semax remains limited, while its long-term safety profile requires further study.
This unregistered product has not been evaluated by SAHPRA for its quality, safety or intended use.
